Objective-To determine the effects of 10 mg and 20 mg/day of escitalopram on objectivelyrecorded hot flashes and on the rectal temperature threshold for sweating.Method-Two studies were performed: 16 women received 10 mg/day and 26 women received 20 mg/day escitalopram for eight weeks. They were randomly assigned in equal numbers to receive active drug or placebo in double-blind fashion. Hot flash frequency was measured with an ambulatory recorder during the first three weeks and during the eighth week of the study. The rectal temperature threshold for sweating was measured during the first and eighth weeks of the study using published methods.Results-In the first study, there were no significant effects whatsoever for any measure. In the second study, the escitalopram group showed an average decline in hot flash frequency of 14.4%, whereas, the placebo group showed an average increase of 6.7% (P < .05). However, there were no significant effects across time for either group. There were no significant effects whatsoever for rectal temperature sweating thresholds.Conclusions-Escitalopram at 10 mg or 20 mg/day is not effective in the treatment of menopausal hot flashes.